.webp "Hepatology – A Clinical Textbook, 11th Edition (2024–2025)")
What is Hepatology: A Clinical Textbook, 11th Edition?
Hepatology – A Clinical Textbook, 11th Edition (2024-2025), is a comprehensive clinical reference covering viral hepatitis, steatotic liver disease, genetic and autoimmune liver diseases, cirrhosis complications, hepatocellular carcinoma, transplantation, and nutrition. The source describes it as useful for physicians, residents, advanced medical students, clinicians, researchers, and others seeking a broader understanding of liver disease.
Introduction
Hepatology is a rapidly changing medical specialty in which diagnostic methods, antiviral therapies, non-invasive assessment, cancer treatment, transplantation, and metabolic liver disease management continue to evolve. Against this background, having a broad clinical reference that brings together major areas of liver disease can be particularly valuable for clinicians and trainees.
Hepatology – A Clinical Textbook, 11th Edition (2024–2025), is designed as a comprehensive clinical textbook covering a wide spectrum of hepatology.
The edition addresses viral hepatitis, steatotic liver disease, genetic and rare liver diseases, autoimmune and cholestatic disorders, alcohol-associated hepatitis, vascular liver disease, acute liver failure, complications of cirrhosis, hepatocellular carcinoma, liver transplantation, and nutrition in liver disease.
The book is edited by Heiner Wedemeyer, Stefan Mauss, Thomas Berg, Verena Keitel, Jürgen Rockstroh, and Christoph Sarrazin. The source describes the edition as a collaborative work involving internationally recognized experts from leading hepatology centers in Germany and elsewhere.
The book is therefore particularly relevant to physicians, residents, and advanced medical students who want a broader understanding of liver disease. The book itself describes its 11th edition as an update of relevant areas of hepatology and identifies physicians, residents, and advanced medical students as an important readership.
Book Overview
Full title
Edition
Editors
- Heiner Wedemeyer
- Stefan Mauss
- Thomas Berg
- Verena Keitel
- Jürgen Rockstroh
- Christoph Sarrazin
Publication year
The edition is identified as 2024–2025. The copyright statement is dated 2025.
Medical specialty
Hepatology, with substantial coverage of gastroenterological, infectious, metabolic, autoimmune, vascular, oncological, transplant, and nutritional aspects of liver disease.
Intended audience
It specifically identifies physicians, residents, and advanced medical students as readers seeking a broader understanding of liver disease. The foreword also identifies clinicians, researchers, and students as an audience for the updated edition.
WHAT THIS BOOK COVERS
One of the defining characteristics of the 11th edition is its breadth. Rather than concentrating on one disease category, the textbook progresses across major clinical areas of hepatology.
Viral hepatitis
The opening portion of the book focuses extensively on viral hepatitis.
The contents include:
- Hepatitis A
- Hepatitis B treatment
- Hepatitis C
- Hepatitis D
- Hepatitis E
- Viral hepatitis and HIV coinfection
- Prophylaxis and vaccination against viral hepatitis
The hepatitis B chapter covers treatment goals, therapeutic endpoints, indications for treatment, acute and chronic infection, special populations, interferons, nucleoside and nucleotide analogues, treatment monitoring, resistance, treatment cessation, and emerging therapeutic strategies.
The hepatitis C chapter addresses epidemiology, transmission, natural history, diagnosis, indications for treatment, direct-acting antiviral therapy, special populations, post-treatment surveillance, virological failure, decompensated liver disease, and rare HCV subtypes.
The dedicated hepatitis D chapter includes virology, epidemiology, pathogenesis, clinical course, diagnosis, treatment, bulevirtide, pegylated interferon alfa, nucleoside and nucleotide analogues, drugs in clinical development, and liver transplantation.
Liver disease staging and non-invasive assessment
A separate chapter addresses grading and staging of liver diseases. It includes clinical stages of cirrhosis, Baveno VII stages, definitions of decompensation and recompensation, clinical scores, liver biopsy, hepatic venous pressure gradient, endoscopic ultrasound-guided portal pressure measurement, liver stiffness, spleen stiffness, and blood-based tests, including FIB-4 and MAFLD fibrosis score.
This section demonstrates the textbook's attention to both traditional invasive assessment and newer non-invasive approaches.
MASLD and MASH
The chapter on MASLD/MASH covers a broad spectrum of the disease, including:
- Epidemiology and prevalence
- Demographics and risk factors
- Pathogenesis
- Human genetic factors
- The microbiome
- Natural history
- Screening
- Diagnosis
- Lifestyle intervention
- Alcohol and coffee
- Pharmacological treatment
- Novel pharmacological approaches
- Intestinal microbiome modification
- Bariatric surgery
- Liver transplantation for MASH
- Follow-up
These topics are explicitly listed in the table of contents.
Genetic and rare liver diseases
The textbook contains a substantial section devoted to genetic liver diseases.
Hemochromatosis is discussed through its classification, HFE-associated disease, epidemiology, pathogenesis, diagnosis, screening, complications, therapy, prognosis, juvenile hereditary hemochromatosis, TFR2-related disease, ferroportin disease, and secondary hemochromatosis.
Wilson disease receives a similarly detailed treatment, including hepatic and neuropsychiatric presentations, diagnostic investigations, Kayser-Fleischer rings, ceruloplasmin, copper measurements, urinary copper, liver biopsy, genetic studies, family screening, medical therapy, treatment monitoring, and liver transplantation.
The book also includes cholestatic syndromes and alpha-1 antitrypsin deficiency, with coverage extending across adult and pediatric liver disease, pulmonary manifestations, genotypes, therapeutic approaches, key messages, and future directions.
Autoimmune and cholestatic liver disease
Autoimmune hepatitis is covered from definition and diagnosis through epidemiology, presentation, prognosis, treatment indications, standard treatment, alternative treatments, overlap syndromes, transplantation, and post-transplant autoimmune hepatitis.
The book also contains dedicated chapters on the following:
- Primary sclerosing cholangitis
- Primary biliary cholangitis
The PSC chapter covers diagnosis, variant and secondary forms, clinical course, risk assessment, inflammatory bowel disease, hepatobiliary malignancy risk, surveillance, medical treatment, endoscopic treatment, and transplantation.
The PBC chapter addresses pathophysiology, diagnosis, symptoms, extrahepatic immune-mediated disease, progression and prognosis, liver stiffness-based risk stratification, HCC surveillance, first- and second-line therapies, quality of life, pruritus, fatigue, sicca symptoms, bone health, and nutritional advice.
Alcohol-associated hepatitis and vascular liver disease
Alcohol-associated hepatitis is examined through harmful alcohol use, pathogenesis, the gut-liver axis, genetic factors, diagnosis, predictive modeling, therapy, nutritional and supportive treatment, transplantation, and alcohol-use-disorder management.
The vascular liver disease chapter includes disorders affecting the hepatic sinusoid, hepatic artery, portal vein, and hepatic veins. Specific conditions include sinusoidal obstruction syndrome, peliosis hepatis, hereditary hemorrhagic telangiectasia, portal vein thrombosis, porto-sinusoidal vascular disease, and Budd-Chiari syndrome.
Acute liver failure
The acute liver failure chapter provides an aetiology-oriented framework, including general standards of care and specific approaches to drug-induced disease, viral hepatitis, autoimmune disease, Amanita intoxication, Wilson disease, acute fatty liver of pregnancy, Budd-Chiari syndrome, and liver transplantation.
Complications of cirrhosis
The textbook devotes a complete chapter to complications of liver cirrhosis.
Topics include:
- Ascites
- Portal hypertensive bleeding
- Hepatic encephalopathy
- Acute kidney injury in cirrhosis
- Infections and cirrhosis-associated immune dysfunction
- Pulmonary complications
- Acute-on-chronic liver failure
For the major complications, the contents are organized around clinical relevance, pathogenesis, diagnostic work-up, and treatment.
Hepatocellular carcinoma
The HCC chapter covers epidemiology, screening and prevention, surveillance of high-risk patients, diagnosis, imaging, histology and biomarkers, classification, BCLC-based treatment allocation, curative approaches, resection, transplantation, ablation, adjuvant therapy, locoregional therapies, systemic therapy, second-line treatment, and supportive therapy for end-stage disease.
Liver transplantation
Transplant hepatology receives a comprehensive chapter addressing timing and indications for transplantation, patient evaluation, pre-transplant management, waiting-list monitoring, viral hepatitis in transplant candidates, HCC candidates, autoimmune and cholestatic disease, living-donor transplantation, perioperative complications, long-term complications, opportunistic infections, rejection, immunosuppression, metabolic complications, recurrent disease, pregnancy after transplantation, inherited metabolic diseases, and transplantation for acute and acute-on-chronic liver failure.
Nutrition and liver diseases
The final major section addresses nutrition and liver disease, including nutritional screening, assessment of malnutrition and obesity, nutritional assessment tools, nutritional management, treatment of malnutrition, energy requirements, nutrient requirements, and nutrition-associated liver injury.
Key Features
- Broad coverage of clinical hepatology, rather than focusing exclusively on viral hepatitis.
- Dedicated coverage of all major viral hepatitis infections represented in the table of contents.
- Detailed treatment-oriented discussion of hepatitis B and C.
- Coverage of emerging areas, including novel therapeutic strategies and therapies in clinical development.
- Integration of invasive and non-invasive approaches to liver disease staging.
- Dedicated treatment of MASLD/MASH, including lifestyle, pharmacological, microbiome, bariatric, and transplantation approaches.
- Coverage of rare and genetic liver disorders, including hemochromatosis, Wilson disease, and alpha-1 antitrypsin deficiency.
- Detailed discussion of cirrhosis complications, with diagnostic and treatment subsections.
- Substantial HCC coverage, including staging and multiple treatment modalities.
- Comprehensive transplant hepatology coverage.
- Nutrition-focused content, including both nutritional assessment and nutrition-associated liver injury.
- Multiauthor expert contribution, with contributors from hepatology and related departments at academic and clinical centers.
Who Should Read This Book
Medical students
It specifically identifies advanced medical students among the intended readership. For students who have already acquired the basic principles of medicine, the book can serve as a broader reference for understanding how different liver diseases are classified, investigated, staged, and managed.
Residents
Residents are explicitly identified as a target audience. The broad structure allows trainees to move beyond isolated disease facts and explore clinical hepatology across infectious, metabolic, autoimmune, vascular, oncological, and transplant settings.
Physicians and specialists
The foreword describes the book as a resource for clinicians and researchers, while the overall contents include detailed treatment and diagnostic material relevant to clinical hepatology.
Nurses and pharmacists
The supplied source does not specifically identify nurses or pharmacists as intended readers. They may find individual topics relevant to multidisciplinary care, but this review cannot claim that the textbook was specifically designed for either profession.
Researchers
Researchers are explicitly included among the readership described in the foreword. The book's coverage of pathogenesis, epidemiology, diagnostic methods, therapeutic development, and future directions may therefore be relevant when a researcher needs a clinical overview of a liver-disease area.
Exam candidates
It does not explicitly market the book as a board-examination or examination-preparation textbook. It contains substantial clinical material that may be educationally useful to trainees, but a dedicated exam-preparation function cannot be confirmed from the supplied source.
Why This Book is Useful
Clinical relevance
The strongest feature apparent from the table of contents is clinical breadth. The book moves from diagnosis and treatment of viral hepatitis to staging of chronic liver disease, metabolic liver disease, rare genetic disorders, cirrhosis complications, liver cancer, transplantation, and nutrition.
This organization mirrors the wide range of problems encountered in clinical hepatology.
Evidence-oriented content
The chapters contain extensive references and discuss contemporary diagnostic and therapeutic developments. The foreword specifically describes advances in antiviral therapy, cancer treatment, metabolic and autoimmune liver diseases, personalized medicine, and non-invasive diagnostic tools as important developments reflected in the new edition.
Practical applications
Several chapters are structured around practical clinical questions. The hepatitis B chapter, for example, explicitly organizes treatment around questions such as why to treat, who to treat, how to treat, how to monitor treatment, and when to stop.
Similarly, the cirrhosis-complications chapter divides major complications into clinical relevance, pathogenesis, diagnostic work-up, and treatment.
Learning efficiency
The textbook's value for learning comes primarily from its organization of related clinical material into dedicated disease-focused chapters. Rather than requiring the reader to consult separate sources for viral hepatitis, cirrhosis, HCC, transplantation, and genetic liver diseases, the book brings these areas together within one clinical hepatology resource.
Board examination usefulness
Although the source does not explicitly describe the book as a board-review resource, its coverage of major hepatology conditions, diagnostic approaches, staging systems, complications, and treatment principles may make selected chapters useful for postgraduate learning. A specific examination-preparation role, however, is not claimed by the source.
Table of Contents Overview
The supplied table of contents identifies 20 major numbered chapters/sections, beginning with hepatitis A and continuing through nutrition and liver diseases. Major sections include:
- Hepatitis A
- Hepatitis B – treatment
- Hepatitis C
- Hepatitis D – diagnosis and treatment
- Hepatitis E
- Viral hepatitis and HIV coinfection
- Prophylaxis and vaccination against viral hepatitis
- Grading and staging of liver diseases
- MASLD / MASH
- Genetic liver diseases
- Autoimmune hepatitis
- Primary sclerosing cholangitis
- Primary biliary cholangitis
- Alcohol-associated hepatitis
- Vascular liver disease
- Acute liver failure
- Complications of liver cirrhosis
- Diagnosis, prognosis & therapy of hepatocellular carcinoma
- Transplant hepatology: a comprehensive update
- Nutrition and liver diseases
The table of contents also demonstrates that many chapters contain detailed subsections addressing epidemiology, pathogenesis, diagnosis, treatment, prognosis, monitoring, and references.
Strengths of The Book
Several strengths can be identified directly from the supplied material.
1. Comprehensive clinical scope
The book does not restrict itself to one category of liver disease. Its contents encompass infectious, metabolic, genetic, autoimmune, cholestatic, alcohol-related, vascular, malignant, acute, chronic, transplant, and nutritional hepatology.
2. Strong treatment orientation
Treatment is a major component of several chapters. Hepatitis B and C, hepatitis D, MASLD/MASH, autoimmune hepatitis, primary biliary cholangitis, alcohol-associated hepatitis, HCC, and transplantation all contain substantial management-focused sections.
3. Attention to modern hepatology
The foreword specifically highlights novel antiviral therapies, targeted treatments for liver and bile duct cancer, advances in metabolic and autoimmune liver diseases, personalized medicine, and non-invasive diagnostics.
4. Multidisciplinary perspective
The contributing-author list includes specialists working across gastroenterology, hepatology, infectious diseases, internal medicine, oncology, and related clinical departments.
5. Useful coverage of complications and advanced disease
The dedicated chapters on cirrhosis complications, acute liver failure, HCC, and transplantation provide coverage extending beyond the diagnosis of uncomplicated liver disease into complex clinical scenarios.
Limitations
The source itself acknowledges an important limitation: hepatology is an evolving field, and the editors state that despite efforts to provide accurate and complete information at publication, technical inaccuracies, typographical errors, or other errors may occur.
The book also advises clinicians to verify current manufacturer information for medicines, including dosage, administration, duration, and contraindications.
A second limitation is inherent to the book format. The first-edition preface emphasizes that hepatology changes rapidly and raises the challenge of keeping textbook information current.
Comparison With Similar Books
This textbook is positioned as a broad clinical hepatology resource, covering both common and specialized areas of liver disease and intended for physicians, residents, advanced medical students, clinicians, researchers, and students seeking a broader understanding of liver disease.
FAQs
Hepatology – A Clinical Textbook is a comprehensive clinical hepatology reference covering viral hepatitis, steatotic liver disease, genetic and autoimmune liver diseases, cirrhosis, hepatocellular carcinoma, transplantation, and nutrition. The supplied edition is the 11th Edition, 2024–2025.
The editors are Heiner Wedemeyer, Stefan Mauss, Thomas Berg, Verena Keitel, Jürgen Rockstroh, and Christoph Sarrazin.
The source specifically identifies physicians, residents, and advanced medical students as readers who may benefit from the textbook. The foreword also identifies clinicians, researchers, and students as part of its intended readership.
The book covers hepatitis A, B, C, D, and E; viral hepatitis and HIV coinfection; vaccination; liver disease staging; MASLD/MASH; genetic liver diseases; autoimmune hepatitis; PSC; PBC; alcohol-associated hepatitis; vascular liver disease; acute liver failure; cirrhosis complications; HCC; liver transplantation; and nutrition in liver disease.
Yes. The dedicated MASLD/MASH chapter covers epidemiology, risk factors, pathogenesis, genetics, microbiome, natural history, screening, diagnosis, lifestyle measures, pharmacological treatment, novel therapies, microbiome modification, bariatric surgery, liver transplantation, and follow-up.
Yes. The HCC chapter covers screening and surveillance, diagnosis, classification, BCLC-based treatment allocation, resection, transplantation, ablation, locoregional therapies, systemic therapy, second-line treatment, and supportive care.
It specifically states that the 11th edition is a source of information for physicians, residents, and advanced medical students seeking a broader understanding of liver disease.
It does not explicitly describe the textbook as an examination or board-review book. Therefore, its suitability as a dedicated exam-preparation resource cannot be confirmed from the source alone.
Conclusion
Hepatology – A Clinical Textbook, 11th Edition, 2024–2025, provides broad coverage of modern clinical hepatology, extending from viral hepatitis and metabolic liver disease to genetic disorders, autoimmune and cholestatic diseases, alcohol-associated hepatitis, vascular disorders, acute liver failure, cirrhosis complications, hepatocellular carcinoma, transplantation, and nutrition.
Its strongest educational characteristic is the breadth of material assembled within a single clinical reference. The contents repeatedly connect disease mechanisms with diagnosis, staging, monitoring, treatment, prognosis, and specialized management.
The edition also reflects developments highlighted by its foreword, including advances in antiviral therapy, cancer treatment, metabolic and autoimmune liver disease, personalized medicine, and non-invasive diagnostics.
For physicians, residents, advanced medical students, clinicians, and researchers seeking a broad reference in hepatology, the 11th edition offers substantial educational coverage. The edition is an updated resource for readers seeking a broader understanding of liver disease.
Because hepatology changes rapidly, the textbook should be understood as a reference corresponding to its publication period rather than a substitute for checking current clinical guidance, drug information, and institutional protocols.
This is consistent with the book's own disclaimer concerning the evolving nature of medical science and the need to verify current drug information.
Overall, Hepatology—A Clinical Textbook, 11th Edition, 2024–2025, is a broad clinical hepatology reference whose major value lies in bringing together the diagnosis and management of a wide range of liver diseases in one structured resource.
Disclaimer
MedBook 4 Free does not own copyrights to this video/book/software. We’re sharing this with our audience ONLY for educational purposes, and we highly encourage our visitors to purchase original licensed software/books.
If someone with copyrights wants us to remove this software/book, please contact us immediately. You can send an email to [email protected] for all DMCA / removal requests.